MedPath

A randomized, single-blind, parallel-controlled study on the efficacy and safety of acupuncture point embedding in the treatment of obesity

Phase 1
Conditions
Obesity
Registration Number
ITMCTR2200005990
Lead Sponsor
Shanghai Post and Telecommunication Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Overweight: 24.0 = BMI < 28.0; obese: BMI = 28.0
(2) Age between 18 and 70 years old, with no restriction on gender
(3) Those who voluntarily participated in this study subject and signed the Informed Consent Form and cooperated with the treatment observation.

Exclusion Criteria

(1) Patients with secondary obesity with underlying diseases such as cortisolism, hypothyroidism, or islet cell tumors.
(2) Patients who have received any weight loss treatment within the last three months.
(3) Patients who have been exposed to acupuncture point burial therapy
(4) Patients with serious circulatory, digestive, urinary, hematopoietic system disorders or malignancies, history of mental disorders
(5) Pregnant and lactating women.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Weight;Body mass index;
Secondary Outcome Measures
NameTimeMethod
High density lipoprotein cholesterol;Total cholesterol;Height;Low density lipoprotein cholestero;Waist;Body fat percentage;Triglyceride;
© Copyright 2025. All Rights Reserved by MedPath